SNPX

TAO Synergies Inc. (SNPX) | Rumor.io

TAO Synergies

SNPX

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)0%

Price to earnings ratio2.76

Market capitalization6M

Earnings per share-11

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-12.8M

Social

What share of all stock conversation is about SNPX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 30

$SNPX shares are surging pre-market, up 7.53% to $6.50.
TAO Synergies ($SNPX) operates as a clinical-stage biopharmaceutical company, developing treatments for Alzheimer's disease, Fragile X Syndrome, Autism, Multiple Sclerosis, and Parkinson's Disease.
$SNPX is expected to raise $100m to invest in TAO Synergies, with the company's market capitalization currently at 9m.

Generated by AI

Sentiment

Of the messages about SNPX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	80% -11.01
Bearish	—	—	—	20% +11.01

Jun 9

$SNPX has shown significant strength, topping at $4.90 and now flagging above $4.00 with stacked EMAs, indicating a potential second leg up.
The stock has experienced a clean breakout over the 3.10–3.50 resistance zone, with massive volume backing the move and closing strong near highs.
$SNPX has demonstrated impressive price action, exploding from $2.38 to $4.40 with a straight rocket move, and has shown the ability to bounce back hard off VWAP with a second wind.

Generated by AI

Topics

Of the messages about SNPX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	0%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	100%

Jun 9

Synaptogenix, Inc. (SNPX) plans to raise $10M to acquire digital assets, with a priority focus on Bittensor's TAO token.
The company aims to acquire $100M worth of TAO tokens, with a current plan to purchase $10M worth of the asset.
Synaptogenix has appointed a crypto expert to lead its digital asset treasury strategy, which will focus exclusively on the top-valued AI token, TAO.

Generated by AI

Community

Of the messages about SNPX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	6.92%
Newcomers	—	—	—	93.08%

Regulars· Dec 16

Synaptogenix announces topline results from Phase 2 trial of Bryostatin-1, with results not meeting primary endpoint for treating advanced Alzheimer's disease.
The company's stock price has been impacted, with a significant decline of -49.0% pre, and a current price of $1.2.
The NIH-sponsored Phase 2 trial's results are seen as a potential catalyst, with some analysts recommending a wait-and-see approach for consolidations before entering with defined risk.

Newcomers· Jun 30

Newcomers are drawn to $SNPX due to its potential for a bullish trend, with some expecting it to "rocket higher".
Investors are comparing $SNPX to $TAO, favoring $SNPX for its protections and simplicity when included in investment accounts.
The company's $100m capital raise to invest in $TAO at a 9m m/c is being closely watched, with some noting that $SNPX is "looking good" and has "strong upside continuation".

Generated by AI

Also Discussed

Investors talking about SNPX also mention

#	Name	Attention
1	Lisata Therapeutics, Inc.LSTA	0%0
2	Uni-Fuels Holdings Ltd.UFG	0%0
3	ENDRA Life Sciences Inc.NDRA	0%0
4	Tempest Therapeutics Inc.TPST	0%+0
5	AIFU Inc. Class A Ordinary ShareAIFU	0%+0
6	KNW - Know Labs, Inc.	——
7	Palvella Therapeutics, Inc.PVLA	0%new
8	Auddia Inc.AUUD	0%0
9	SGD - Safe and Green Development Corporation	——
10	BG Staffing IncBGSF	0%new

TAO Synergies Inc.

Healthcare
Biotechnology

TAO Synergies Inc. is a public company positioned at the intersection of biotechnology and digital finance. Originally established as Synaptogenix, Inc. in 2012 and rebranded in 2025, the company has historically operated as a biopharmaceutical developer, focusing on advancing Bryostatin-1, a therapeutic candidate for Alzheimer’s disease and several other neurodegenerative conditions, including Fragile X syndrome and Multiple Sclerosis, through clinical and preclinical stages. In mid-2025, TAO Synergies Inc. shifted its strategic direction to become the first pure-play public company dedicated to leveraging synergies between cryptocurrency and artificial intelligence (AI). The company's treasury strategy centers exclusively on acquiring and staking TAO, the native token of Bittensor—a blockchain network focused on decentralized machine learning and AI. This approach positions TAO Synergies Inc. at the forefront of both digital asset management and AI innovation, reflecting its commitment to capitalizing on the growth and integration of these rapidly evolving sectors within the broader financial and technological markets.

Website

Location

181 Westchester Avenue

Port Chester, NY, 10573

United States

Social

What share of all stock conversation is about SNPX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 30

$SNPX shares are surging pre-market, up 7.53% to $6.50.
TAO Synergies ($SNPX) operates as a clinical-stage biopharmaceutical company, developing treatments for Alzheimer's disease, Fragile X Syndrome, Autism, Multiple Sclerosis, and Parkinson's Disease.
$SNPX is expected to raise $100m to invest in TAO Synergies, with the company's market capitalization currently at 9m.

Generated by AI

Sentiment

Of the messages about SNPX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	80% -11.01
Bearish	—	—	—	20% +11.01

Jun 9

$SNPX has shown significant strength, topping at $4.90 and now flagging above $4.00 with stacked EMAs, indicating a potential second leg up.
The stock has experienced a clean breakout over the 3.10–3.50 resistance zone, with massive volume backing the move and closing strong near highs.
$SNPX has demonstrated impressive price action, exploding from $2.38 to $4.40 with a straight rocket move, and has shown the ability to bounce back hard off VWAP with a second wind.

Generated by AI

Topics

Of the messages about SNPX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	0%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	100%

Jun 9

Synaptogenix, Inc. (SNPX) plans to raise $10M to acquire digital assets, with a priority focus on Bittensor's TAO token.
The company aims to acquire $100M worth of TAO tokens, with a current plan to purchase $10M worth of the asset.
Synaptogenix has appointed a crypto expert to lead its digital asset treasury strategy, which will focus exclusively on the top-valued AI token, TAO.

Generated by AI

Community

Of the messages about SNPX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	6.92%
Newcomers	—	—	—	93.08%

Regulars· Dec 16

Synaptogenix announces topline results from Phase 2 trial of Bryostatin-1, with results not meeting primary endpoint for treating advanced Alzheimer's disease.
The company's stock price has been impacted, with a significant decline of -49.0% pre, and a current price of $1.2.
The NIH-sponsored Phase 2 trial's results are seen as a potential catalyst, with some analysts recommending a wait-and-see approach for consolidations before entering with defined risk.

Newcomers· Jun 30

Newcomers are drawn to $SNPX due to its potential for a bullish trend, with some expecting it to "rocket higher".
Investors are comparing $SNPX to $TAO, favoring $SNPX for its protections and simplicity when included in investment accounts.
The company's $100m capital raise to invest in $TAO at a 9m m/c is being closely watched, with some noting that $SNPX is "looking good" and has "strong upside continuation".

Generated by AI

TAO Synergies

Social

Jun 30

Sentiment

Jun 9

Topics

Jun 9

Community

Regulars· Dec 16

Newcomers· Jun 30

Also Discussed

TAO Synergies Inc.

Company Information

Location

Also Discussed

Social

Jun 30

Sentiment

Jun 9

Topics

Jun 9

Community

Regulars· Dec 16

Newcomers· Jun 30